AIRLINK 74.40 Increased By ▲ 0.11 (0.15%)
BOP 4.95 No Change ▼ 0.00 (0%)
CNERGY 4.37 No Change ▼ 0.00 (0%)
DFML 39.29 Increased By ▲ 0.49 (1.26%)
DGKC 85.33 Increased By ▲ 0.51 (0.6%)
FCCL 21.33 Increased By ▲ 0.12 (0.57%)
FFBL 33.80 Decreased By ▼ -0.32 (-0.94%)
FFL 9.69 Decreased By ▼ -0.01 (-0.1%)
GGL 10.50 Increased By ▲ 0.08 (0.77%)
HBL 112.99 Decreased By ▼ -0.01 (-0.01%)
HUBC 137.00 Increased By ▲ 0.80 (0.59%)
HUMNL 12.02 Increased By ▲ 0.12 (1.01%)
KEL 4.74 Increased By ▲ 0.03 (0.64%)
KOSM 4.42 Decreased By ▼ -0.02 (-0.45%)
MLCF 37.97 Increased By ▲ 0.32 (0.85%)
OGDC 138.19 Increased By ▲ 1.99 (1.46%)
PAEL 25.30 Increased By ▲ 0.20 (0.8%)
PIAA 20.17 Increased By ▲ 0.93 (4.83%)
PIBTL 6.67 Decreased By ▼ -0.04 (-0.6%)
PPL 122.80 Increased By ▲ 0.70 (0.57%)
PRL 26.85 Increased By ▲ 0.20 (0.75%)
PTC 13.97 Increased By ▲ 0.04 (0.29%)
SEARL 57.70 Increased By ▲ 0.48 (0.84%)
SNGP 67.50 Decreased By ▼ -0.10 (-0.15%)
SSGC 10.31 Increased By ▲ 0.06 (0.59%)
TELE 8.44 Increased By ▲ 0.04 (0.48%)
TPLP 11.18 Increased By ▲ 0.05 (0.45%)
TRG 63.15 Increased By ▲ 0.34 (0.54%)
UNITY 26.55 Increased By ▲ 0.05 (0.19%)
WTL 1.41 Increased By ▲ 0.06 (4.44%)
BR100 7,817 Increased By 7 (0.09%)
BR30 25,289 Increased By 139.2 (0.55%)
KSE100 74,997 Increased By 40.8 (0.05%)
KSE30 24,099 Increased By 16.3 (0.07%)
World

Britain has given 10 million people a first COVID-19 vaccine dose

  • "This is a hugely significant milestone in our national effort against this virus."
  • The country approved vaccines developed by Pfizer-BioNTech and Oxford University-AstraZeneca earlier than the United States and Europe, enabling it to make an early start on roll-out.
Published February 3, 2021

LONDON: More than 10 million people in Britain have received the first dose of a COVID-19 vaccine, Health Secretary Matt Hancock said on Wednesday, describing the milestone as "hugely significant".

Britain is aiming to offer a shot to all over-70s, highly vulnerable people, and frontline medics and care workers by the middle of February.

The pace of vaccinations, which are running at 400,000 shots a day, puts Britain only behind Israel and the United Arab Emirates in the number of doses delivered per 100 people.

"This is a hugely significant milestone in our national effort against this virus," Hancock said on Twitter.

The country approved vaccines developed by Pfizer-BioNTech and Oxford University-AstraZeneca earlier than the United States and Europe, enabling it to make an early start on roll-out.

It also struck supply deals with manufacturers early in the development of the vaccines, helping it avoid some of the supply shortages that are hampering European programmes.

Comments

Comments are closed.